THE UNIVERSITY OF TEXAS – HOUSTON MEDICAL SCHOOL
DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES
LECTURE SERIES
DECEMBER 2002
WHERE: MSI AUDITORIUM
(except for December 10)
TIME: 11:00 a.m. – 12:00 p.m.
(except for December 10)
December 4
PEDRO RUIZ, M.D.
Professor and Vice Chair
Department of Psychiatry & Behavioral Sciences
University of Texas Medical School at Houston
“Substance Abuse in the United States: Current
Issues and Future Perspectives”
* * * SPECIAL LECTURE *
* *
December 10 (Tuesday)
3:00 p.m.
PHILLIP RESNICK, M.D.
HCPC gym
Professor of Psychiatry
Case Western Reserve University
Cleveland, Ohio
"The Andrea Yates Trial: Implications for
Psychiatry"
December 11
JOHN D. JUSTICE, M.D.
President and CEO
West Virginia Psychiatric & Forensic Services
“Ethical and Legal Considerations in Psychopharmacotherapy”
--- CANCELLED ---
December 18
FACULTY MEETING
(Psychiatry Department Faculty only)
11:00 a.m. - 12:00 p.m.
HCPC gym
December 25
NO LECTURE SCHEDULED
Christmas Holidays
OVERALL EDUCATIONAL OBJECTIVES:
The participants should be able to 1) identify and describe current research
and clinical practice advances in the fields of psychiatry, psychology
and other mental health care professions, and 2) Summarize social dynamics
and/or ethical issues related to mental health science research activities
and patient care.
TARGET AUDIENCE:
MDs (Psychiatrists), psychologists, nurses, social workers and other mental
health professionals.
ACCREDITATION:
The University of Texas Medical School at Houston is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing
medical education for physicians.
CREDIT HOUR DESIGNATION:
The University of Texas-Houston Medical School designates this educational
activity for a maximum of one hour in category 1 credit towards the AMA
Physicians Recognition Award. Each physician should claim only those
hours of credit that he/she actually spent in the educational activity.
ACKNOWLEDGEMENT:
Grateful acknowledgement is made to AstraZeneca, Eli Lilly, GlaxoSmithKline,
Janssen, Pfizer, Solvay and Wyeth-Ayerst for their generous support of
this CME activity.